Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 438,290 | 214,054 | 679,089 | 506,882 | 325,944 |
| Depreciation Amortization | 56,186 | 28,331 | 111,900 | 83,180 | 54,633 |
| Income taxes - deferred | -12,932 | -3,757 | -35,065 | -36,890 | -23,517 |
| Accounts receivable | -61,158 | -44,133 | -41,398 | -35,061 | -53,794 |
| Accounts payable and accrued liabilities | -4,155 | 3,327 | 3,467 | -3,930 | -6,735 |
| Other Working Capital | -130,310 | -70,609 | -273,530 | -229,597 | -206,951 |
| Other Operating Activity | 98,305 | 56,699 | 98,521 | 84,972 | 90,976 |
| Operating Cash Flow | $384,226 | $183,912 | $542,984 | $369,556 | $180,556 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -25,000 | -25,000 | -25,000 |
| PPE Investments | -66,981 | -39,511 | -148,838 | -99,609 | -61,924 |
| Net Acquisitions | N/A | N/A | -11,512 | -11,512 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -10,000 | -10,000 | -10,000 |
| Other Investing Activity | 0 | 0 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $-66,981 | $-39,511 | $-195,350 | $-146,121 | $-96,924 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 559,500 | 537,500 |
| Debt Repayment | N/A | N/A | -75,000 | -75,000 | -75,000 |
| Common Stock Issued | 23,086 | 12,796 | 35,747 | N/A | N/A |
| Common Stock Repurchased | -9,676 | -9,597 | -830,317 | -756,243 | -583,450 |
| Other Financing Activity | -310,524 | -149,280 | 498,634 | 17,527 | 15,563 |
| Financing Cash Flow | $-297,114 | $-146,081 | $-370,936 | $-254,216 | $-105,387 |
| Exchange Rate Effect | 161 | 501 | -8,606 | -14,497 | -8,337 |
| Beginning Cash Position | 112,546 | 112,546 | 144,454 | 144,454 | 144,454 |
| End Cash Position | 132,838 | 111,367 | 112,546 | 99,176 | 114,362 |
| Net Cash Flow | $20,292 | $-1,179 | $-31,908 | $-45,278 | $-30,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | 384,226 | 183,912 | 542,984 | 369,556 | 180,556 |
| Capital Expenditure | -66,981 | -39,511 | -148,838 | -99,609 | -61,924 |
| Free Cash Flow | 317,245 | 144,401 | 394,146 | 269,947 | 118,632 |